Orhan Sezer

Active 1985–2021

82
Papers
25,274
Citations
78
h-index
82
i10-index

Citations

Citations per year for Orhan Sezer1987: 1 citations1988: 2 citations1990: 1 citations1991: 1 citations1993: 1 citations1994: 1 citations1995: 1 citations1996: 1 citations1998: 1 citations1999: 1 citations2001: 8 citations2002: 25 citations2003: 55 citations2004: 53 citations2005: 56 citations2006: 74 citations2007: 105 citations2008: 113 citations2009: 176 citations2010: 171 citations2011: 232 citations2012: 160 citations2013: 208 citations2014: 221 citations2015: 193 citations2016: 234 citations2017: 192 citations2018: 143 citations2019: 669 citations2020: 674 citations2021: 636 citations2022: 444 citations2023: 223 citations2024: 486 citations2025: 185 citations2026: 10 citations1989: no citations, so this year is not shown1992: no citations, so this year is not shown1997: no citations, so this year is not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,931 citing papers, 21.4% of this breakdownUnited Kingdom: 683 citing papers, 7.6% of this breakdownItaly: 614 citing papers, 6.8% of this breakdownGermany: 611 citing papers, 6.8% of this breakdownFrance: 474 citing papers, 5.3% of this breakdownChina: 432 citing papers, 4.8% of this breakdownSpain: 430 citing papers, 4.8% of this breakdownNetherlands: 383 citing papers, 4.2% of this breakdownCanada: 301 citing papers, 3.3% of this breakdownGreece: 287 citing papers, 3.2% of this breakdownAustralia: 232 citing papers, 2.6% of this breakdownBelgium: 225 citing papers, 2.5% of this breakdown
0%21.4%Other 26.7%

Fields

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology20.2%
  • Immunology and Microbiology0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Health Professions0.8%
  • Engineering0.4%
  • Other1.6%

Topics

  • Multiple Myeloma Research and Treatments17.9%
  • Protein Degradation and Inhibitors6.5%
  • Amyloidosis: Diagnosis, Treatment, Outcomes4.8%
  • Peptidase Inhibition and Analysis4.2%
  • Cancer Treatment and Pharmacology2.6%
  • Bone health and treatments2%
  • Other62%

Coauthors

All papers

Open in search
  1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 cited by 4,869

  2. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 1,034

  3. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    Authors: , , , , , , , , , , , , - American Journal of Hematology 2005 cited by 1,422

  4. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 cited by 268

  5. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer

    Authors: , , , , , , , , , , , , - European Journal of Cancer 2009 cited by 454

  6. Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson, Joan Bladé - British Journal of Haematology 2021 cited by 174

  7. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2015 cited by 398

  8. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rafaël Fonseca, Giampaolo Merlini, Juan José Lahuerta, Joan Bladé, Robert Z. Orlowski, Jatin J. Shah, on behalf of the International Myeloma Working Group - Leukemia 2012 cited by 383

  9. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Boccadoro, Brian G.M. Durie, Pieter Sonneveld, M. A. Hussein, on behalf of the International Myeloma Working Group - Leukemia 2007 cited by 839

  10. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Powles, S. Vincent Rajkumar, Brian G.M. Durie, on behalf of the International Myeloma Working Group - Leukemia 2008 cited by 809

  11. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C Anderson Kenneth, Michael Attal, Hervé Avet‐Loiseau, Ashraf Badros, Dalsu Baris, Bart Barlogie, Régis Bataille, Meral Beksaç, Andrew Belch, Dina Ben‐Yehuda, Bill Bensinger, P. Leif Bergsagel, Jenny Bird, Joan Bladé, Mario Boccadoro, Michèle Cavo, Asher Chanan‐Khan, Wen Ming Chen, Tony Child, James Chim, Wee Joo Chng, Ray Comenzo, John Crowley, William S. Dalton, Faith E. Davies, Cármino Antônio De Souza, Michel Delforge, Meletios Α. Dimopoulos, Angela Dispenzieri, Johannes Drach, Matthew T. Drake, Brian G.M. Durie, Hermann Einsele, Theirry Facon, Dorotea Fantl, Jean‐Paul Fermand, Rafaël Fonseca, Gösta Gahrton, Ramón García‐Sánz, Christina Gasparetto, Morie A. Gertz, John Gibson, Sergio Giralt, Hartmut Goldschmidt, Philip R. Greipp, Roman Hájek, Izhar Hardan, Parameswaran Hari, Jean‐Luc Harousseau, Hiroyuki Hata, Yutaka Hattori, Tom Heffner, Joy Ho, Vânia Hungria, Shinsuke Ida, Peter Jacob, Sundar Jagannath, Hans Erik Johnsen, Jian Hou, Douglas Joshua, Artur Jurczyszyn, Michio Kawano, Nicolaus Kröger, Shaji Kumar, Robert A. Kyle, Martha Q. Lacy, Juan José Lahuerta, Ola Landgren, Jacob P. Laubach, Jae Hoon Lee and 60 more - Leukemia 2011 cited by 721

  12. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 394

  13. Second primary malignancies in multiple myeloma: an overview and IMWG consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evangelos Terpos, Ingemar Turesson, Saad Z. Usmani, Brendan M. Weiss, Antonio Palumbo - Annals of Oncology 2016 cited by 151

  14. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer

    Authors: , , , , , , , , , , , , - European Journal of Cancer 2004 cited by 225

  15. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer

    Authors: , , , , , , , , , , - European Journal of Cancer 2003 cited by 415

  16. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meletios Α. Dimopoulos, Philippe Moreau, Robert Z. Orlowski, Jesús F. San Miguel, Kenneth C. Anderson, Antonio Palumbo, Shaji Kumar, S. Vincent Rajkumar, Brian G.M. Durie, Paul G. Richardson - Leukemia 2015 cited by 255

  17. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire

    Authors: , , , , , , , , , - European Journal of Cancer 2007 cited by 216

  18. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

    Authors: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2009 cited by 878

  19. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hematology & Oncology 2018 cited by 322

  20. Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 409

  21. Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2009 cited by 233

  22. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer

    Authors: , , , , , , , , - European Journal of Cancer 2001 cited by 201

  23. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

    Authors: , , , , , , , , , , , , , , , , , , , - Haematologica 2014 cited by 174

  24. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

    Authors: , , , , , , , , , , , , , - Leukemia 2009 cited by 482